CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures necessitate cutting-edge advancements in analytical methods and tools to effectively characterize the genome-edited products utilizing CRISPR technology.

As industry experts tread unchartered territory, the inaugural CRISPR-Based Therapy Analytical Development Summit has been convened, gathering more than 60 distinguished experts in analytical development devoted to the creation, refinements and implementation of more robust analytical tools specifically tailored to CRISPR-based constructs.

Within this intimate space, we will adopt a shared consensus and delve into a comprehensive array of analytical techniques central to any CRISPR-based toolkit. Topics of discussion will span pioneering technology that includes everything from novel methods to characterize the guide RNA and whole CRISPR complex, to the use of next-generation sequencing (NGS) to detect and assess off-targets for superior safety evaluations.

In response to the regulatory bodies’ insistence on high-quality data to substantiate the safety and efficacy of genome-edited products, this summit is imperative to all individual engaged in the development of analytical tools and methodologies utilizing CRISPR technology as we build for better guidance around CRISPR-edited products.

⌛ Event Dates & Venue

30 Oct - 01 Nov 2023, 9:00 am - 3:00 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Drug Developer Pricing - Conference + Workshop Day: USD 4297.00, Drug Developer Pricing - Conference Only: USD 2999.00, Academic Pricing - Conference + Workshop Day: USD 3697.00, Academic Pricing - Conference Only: USD 2599.00, Solution Provider Pricing - Conference + Workshop Day: USD 5297.00, Solution Provider Pricing - Conference Only: USD 3799.00

◑ Topics | Categories